Universe Pharmaceuticals Inc
(NASDAQ) UPC
Universe Pharmaceuticals Inc Financials at a Glance
Market Cap
$1.78M
Revenue (TTM)
$40.88M
Net Income (TTM)
$12.40M
EPS (TTM)
$-10.13
P/E Ratio
-0.31
Dividend
$0.00
Beta (Volatility)
0.07 (Low)
Dividend
$0.00
Beta (Volatility)
0.07 (Low)
Price
$2.80
Volume
5
Open
$2.78
Price
$2.80
Volume
5
Open
$2.78
Previous Close
$2.80
Daily Range
$2.78 - $2.80
52-Week Range
$2.00 - $11.00
Dividend
$0.00
Beta (Volatility)
0.07 (Low)
Price
$2.80
Volume
5
Open
$2.78
Previous Close
$2.80
Daily Range
$2.78 - $2.80
52-Week Range
$2.00 - $11.00
UPC News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Universe Pharmaceuticals Inc
Industry
Pharmaceuticals
Sector
Health CareEmployees
216
CEO
Gang Lai
Website
www.universe-pharmacy.comHeadquarters
Ji'An, 343100, CN
UPC Financials
Key Financial Metrics (TTM)
Gross Margin
35%
Operating Margin
-16%
Net Income Margin
-21%
Return on Equity
-7%
Return on Capital
-5%
Return on Assets
-5%
Earnings Yield
-3.23%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.78M
Shares Outstanding
563.30K
Volume
5
Short Interest
0.00%
Avg. Volume
13.95K
Financials (TTM)
Gross Profit
$6.30M
Operating Income
$2.92M
EBITDA
$2.92M
Operating Cash Flow
$5.05M
Capital Expenditure
$347.19K
Free Cash Flow
$5.40M
Cash & ST Invst.
$33.59M
Total Debt
$9.26M
Universe Pharmaceuticals Inc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.71M
-37.1%
Gross Profit
$3.14M
-22.8%
Gross Margin
36.03%
N/A
Market Cap
$1.78M
N/A
Market Cap/Employee
$7.91K
N/A
Employees
225
N/A
Net Income
$387.30K
+92.9%
EBITDA
$36.21K
+99.0%
Quarterly Fundamentals
Net Cash
$24.34M
+86.9%
Accounts Receivable
$13.19M
+22.9%
Inventory
$2.19M
-34.4%
Long Term Debt
$0.00
N/A
Short Term Debt
$9.26M
+68.8%
Return on Assets
-5.30%
N/A
Return on Invested Capital
-5.19%
N/A
Free Cash Flow
$7.78M
-111.3%
Operating Cash Flow
$7.61M
-109.2%